Tag: pharmaceutical exclusivity

Formulation patents on drug combinations let pharmaceutical companies extend market exclusivity by patenting specific doses, delivery methods, or formulations-not the drugs themselves. This strategy delays generics and boosts profits, but faces growing legal and regulatory pushback.